This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Michal Zimerman: Innovator in Stem Cell Research
Introduction
Michal Zimerman is a prominent inventor based in Caesarea, Israel. He has made significant contributions to the field of stem cell research, particularly in the area of hepatocyte maturation. His innovative approaches have the potential to advance medical science and improve therapeutic applications.
Latest Patents
Zimerman holds a patent titled "Methods of inducing metabolic maturation of human pluripotent stem cells—derived hepatocytes." This patent outlines methods for increasing the metabolic maturation of immature hepatocytes. The process involves contacting immature hepatocytes that express alpha-fetoprotein (AFP) and albumin with effective amounts of various fatty acids or small molecules. These include amphipathic carboxylic acids, Thiazolidinedione (TZD), and several other compounds. The patent also discusses isolated hepatocytes and their potential uses.
Career Highlights
Zimerman is associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work has been instrumental in bridging the gap between research and practical applications in regenerative medicine. His innovative methods are paving the way for advancements in liver disease treatment and other related fields.
Collaborations
Zimerman has collaborated with notable colleagues, including Yaakov Nahmias and Gahl Levy. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in stem cell technology.
Conclusion
Michal Zimerman's contributions to stem cell research exemplify the impact of innovative thinking in medicine. His patent on hepatocyte maturation methods showcases his commitment to advancing scientific knowledge and improving healthcare solutions.